Eligibility Nasopharyngeal Carcinoma NCT01612286

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
Description

ID.1

Data type

boolean

have measurable lesions
Description

ID.2

Data type

boolean

no dysfunction of the major organs
Description

ID.3

Data type

boolean

can understand this study and give a signed informed consent certificates
Description

ID.4

Data type

boolean

without a history of allergic reaction to the biological agents
Description

ID.5

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating women; women of child-bearing age without contraception
Description

ID.6

Data type

boolean

with a serious infection or dysfunction of the major organs
Description

ID.7

Data type

boolean

have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
Description

ID.8

Data type

boolean

allergic to the escherichia coli preparations
Description

ID.9

Data type

boolean

cann't understand this study and give a signed informed consent certificates
Description

ID.10

Data type

boolean

Similar models

Eligibility Nasopharyngeal Carcinoma NCT01612286

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
boolean
ID.2
Item
have measurable lesions
boolean
ID.3
Item
no dysfunction of the major organs
boolean
ID.4
Item
can understand this study and give a signed informed consent certificates
boolean
ID.5
Item
without a history of allergic reaction to the biological agents
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
pregnant or lactating women; women of child-bearing age without contraception
boolean
ID.7
Item
with a serious infection or dysfunction of the major organs
boolean
ID.8
Item
have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
boolean
ID.9
Item
allergic to the escherichia coli preparations
boolean
ID.10
Item
cann't understand this study and give a signed informed consent certificates
boolean